Chen, N. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in wuhan, china: a descriptive study. Lancet 395 (10223), 507–513. https://doi.org/10.1016/S0140-6736(20)30211-7 (2020).
https://www.worldometers.info/coronavirus/. Accessed Date Oct. 09, 2022.
Silveira, D. et al. COVID-19: is there evidence for the use of herbal medicines as adjuvant symptomatic therapy?? Front. Pharmacol. 11, 581840. https://doi.org/10.3389/fphar.2020.581840 (2020).
Singhal, T. A review of coronavirus Disease-2019 (COVID-19). Indian J. Pediatr. 87 (4), 281–286. https://doi.org/10.1007/s12098-020-03263-6 (2020).
Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China . Lancet https://doi.org/10.1016/S0140-6736(20)30252-X (2020).
Xu, X. W. et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. bmj https://doi.org/10.1136/bmj.m792 (2020).
Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in wuhan, china: a retrospective cohort study. Lancet 395 (10229), 1054–1062. https://doi.org/10.1016/S0140-6736(20)30566-3 (2020). Erratum in: Lancet. 2020;395(10229):1038. https://doi.org/10.1016/S0140-6736(20)30638-3.
Terpos, E. et al. Hematological findings and complications of COVID-19. Am. J. Hematol. 95 (7), 834–847. https://doi.org/10.1002/ajh.25829 (2020).
Cui, S., Chen, S., Li, X., Liu, S. & Wang, F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J. Thromb. Haemost. 18 (6), 1421–1424. https://doi.org/10.1111/jth.14830 (2020).
Dourado, D. et al. Will Curcumin nanosystems be the next promising antiviral alternatives in COVID-19 treatment trials? Biomed. Pharmacother. 139, 111578. https://doi.org/10.1016/j.biopha.2021.111578 (2021).
Thota, S. M., Balan, V. & Sivaramakrishnan, V. Natural products as home-based prophylactic and symptom management agents in the setting of COVID-19. Phytother Res. 34 (12), 3148–3167. https://doi.org/10.1002/ptr.6794 (2020).
Xin, S. et al. Clinical retrospective study on the efficacy of Qingfei Paidu Decoction combined with Western medicine for COVID-19 treatment. Biomed. Pharmacother. 129, 110500. https://doi.org/10.1016/j.biopha.2020.110500 (2020).
Khajebishak, Y., Yaghchian, M., Mohajeri, M. & Payahoo, L. Ginger (Zingiber officinal Roscoe): A review of its therapeutic uses based on the perspective of modern science and traditional Persian medicine. J. Islamic Iran. Traditional Med. 9 (3), 239–250 (2018). (Persian).
Khosrojerdi, A., Mashayekhi, K. & Zare Marzouni, H. Curcumin (extracted from turmeric) and its therapeutic effects. Jorjani Biomed. J. 4 (2), 1–20 (2016). (Persian).
Goel, A., Kunnumakkara, A. B. & Aggarwal, B. B. Curcumin as curecumin: from kitchen to clinic. Biochem. Pharmacol. 75 (4), 787–809. https://doi.org/10.1016/j.bcp.2007.08.016 (2008).
Minassi, A., Sánchez-Duffhues, G., Collado, J. A., Muñoz, E. & Appendino, G. Dissecting the pharmacophore of curcumin. Which structural element is critical for which action? J. Nat. Prod. 76 (6), 1105–1112. https://doi.org/10.1021/np400148e (2013).
Boroumand, N., Samarghandian, S. & Hashemy, S. I. Immunomodulatory, anti-inflammatory, and antioxidant effects of Curcumin. J. Herbmed Pharmacol. 7 (4), 211–219. https://doi.org/10.15171/jhp.2018.33 (2018).
Allegra, A. et al. Anticancer activity of Curcumin and its analogues: preclinical and clinical studies. Cancer Invest. 35 (1), 1–22. https://doi.org/10.1080/07357907.2016.1247166 (2017).
Hurley, L. L. et al. Antidepressant-like effects of Curcumin in WKY rat model of depression is associated with an increase in hippocampal BDNF. Behav. Brain Res. 239, 27–30. https://doi.org/10.1016/j.bbr.2012.10.049 (2013).
Jennings, M. R. & Parks, R. J. Curcumin as an antiviral agent. Viruses 12 (11), 1242. https://doi.org/10.3390/v12111242 (2020).
Wen, C. C. et al. Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. J. Med. Chem. 50 (17), 4087–4095. https://doi.org/10.1021/jm070295s (2007).
Lu, R. et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395 (10224), 565–574. https://doi.org/10.1016/S0140-6736(20)30251-8 (2020).
Zahedipour, F. et al. Potential effects of Curcumin in the treatment of COVID-19 infection. Phytother Res. 34 (11), 2911–2920. https://doi.org/10.1002/ptr.6738 (2020).
Roy, A. et al. Can concomitant use of zinc and Curcumin with other immunity-boosting nutraceuticals be the arsenal against COVID-19? Phytother Res. 34 (10), 2425–2428. https://doi.org/10.1002/ptr.6766 (2020).
White B Ginger: an overview. Am. Fam Physician. 75 (11), 1689–1691 (2007). PMID: 17575660.
Dissanayake, K. G. C., Liyanage, W. A., Waliwita, C. & Liyanage, R. P. A review on medicinal uses of Zingiber officinale (Ginger). Int. J. Health Sci. Res. 10, 142–148 (2020).
Shahzad, F., Anderson, D. & Najafzadeh, M. The antiviral, Anti-Inflammatory effects of natural medicinal herbs and mushrooms and SARS-CoV-2 infection. Nutrients 12 (9), 2573. https://doi.org/10.3390/nu12092573 (2020).
Shah, A. & Krishnamurthy, R. Swine flu and its herbal remedies. Int. J. Eng. Sci. 2 (5), 68–78 (2013).
Bhutada, R. S., Rathi, R. & Dasar, D. Immunity boosting diet during COVID 19. Int. J. Pharm. Sci. Res. 11, 832–838 (2020).
Pawar, K. S. et al. Oral Curcumin with Piperine as adjuvant therapy for the treatment of COVID-19: A randomized clinical trial. Front. Pharmacol. 12, 669362. https://doi.org/10.3389/fphar.2021.669362 (2021).
Saber-Moghaddam, N. et al. Oral nano-curcumin formulation efficacy in management of mild to moderate hospitalized coronavirus disease-19 patients: an open label nonrandomized clinical trial. Phytother Res. 35 (5), 2616–2623. https://doi.org/10.1002/ptr.7004 (2021).
Ahmad, R. S. et al. iochemistry, safety, pharmacological activities, and clinical applications of turmeric: a mechanistic review. Evidence-Based Complementary and Alternative Medicine https://doi.org/10.1155/2020/7656919 (2020).
White, C. M., Pasupuleti, V., Roman, Y. M., Li, Y. & Hernandez, A. V. Oral turmeric/curcumin effects on inflammatory markers in chronic inflammatory diseases: A systematic review and meta-analysis of randomized controlled trials. Pharmacol. Res. 146, 104280. https://doi.org/10.1016/j.phrs.2019.104280 (2019).
Jafarzadeh, A. & Nemati, M. Therapeutic potentials of ginger for treatment of multiple sclerosis: A review with emphasis on its immunomodulatory, anti-inflammatory and anti-oxidative properties. J. Neuroimmunol. 324, 54–75. https://doi.org/10.1016/j.jneuroim.2018.09.003 (2018).
Jalali, M. et al. The effects of ginger supplementation on markers of inflammatory and oxidative stress: A systematic review and meta-analysis of clinical trials. Phytother Res. 34 (8), 1723–1733. https://doi.org/10.1002/ptr.6638 (2020).
Verma, R. K. et al. Medicinal properties of turmeric (Curcuma longa L.): A review. Int. J. Chem. Stud. 6 (4), 1354–1357 (2018).
Zeng, F. et al. Association of inflammatory markers with the severity of COVID-19: A meta-analysis. Int. J. Infect. Dis. 96, 467–474. https://doi.org/10.1016/j.ijid.2020.05.055 (2020).
Gupta, D., Jain, A., Chauhan, M. & Dewan, S. Inflammatory markers as early predictors of disease severity in COVID-19 patients admitted to intensive care units: A retrospective observational analysis. Indian J. Crit. Care Med. 26 (4), 482–486. https://doi.org/10.5005/jp-journals-10071-24171 (2022).
Hewlings, S. J., Kalman, D. S. & Curcumin A review of its effects on human health. Foods 6 (10), 92. https://doi.org/10.3390/foods6100092 (2017).
Ayustaningwarno, F., Anjani, G., Ayu, A. M. & Fogliano, V. A critical review of ginger’s (Zingiber officinale) antioxidant, anti-inflammatory, and Immunomodulatory activities. Front. Nutr. 11, 1364836. https://doi.org/10.3389/fnut.2024 (2024).
Sonam, S. B. V., Samatha, A., Mansi, S., Shubham, R. S. & Raziya, B. S. Anti-Inflammatory effects of Zingiber officinale: A comprehensive review of its bioactive compounds and therapeutic potential. Medtigo J. Pharmacol. 1 (1), e3061113. https://doi.org/10.63096/medtigo3061113 (2024).
Ahkam, A. H., Hermanto, F. E., Alamsyah, A., Aliyyah, I. H. & Fatchiyah, F. Virtual prediction of antiviral potential of ginger (Zingiber officinale) bioactive compounds against Spike and MPro of SARS-CoV2 protein. Berk Penelit Hayati J. Biol. Res. 25 (2), 52–57. https://doi.org/10.23869/50 (2020).
Haridas, M. et al. Compounds of citrus medica and Zingiber officinale for COVID-19 inhibition: in Silico evidence for cues from ayurveda. Futur J. Pharm. Sci. 7 (1), 13. https://doi.org/10.1186/s43094-020-00171-6 (2021).
Bagad, A. S., Joseph, J. A., Bhaskaran, N. & Agarwal, A. Comparative evaluation of anti-inflammatory activity of curcuminoids, turmerones, and aqueous extract of Curcuma longa. Advances in Pharmacological and Pharmaceutical Sciences https://doi.org/10.1155/2013/805756 (2013).
Srinivasan, K. Anti-Inflammatory influences of culinary spices and their bioactives. Food Rev. Int. 38 (sup 1), 1–17. https://doi.org/10.1080/87559129.2020.1839761 (2020).
Sandhiutami, N. M. D. et al. Enhanced wound healing effect of Areca Catechu L. Ointment via antibacterial activity and Anti-Inflammatory process at grade IIA burns in rats. J. Herbmed Pharmacol. 12 (3), 388–398. https://doi.org/10.34172/jhp.2023.42 (2023).
Bagherniya, M. et al. The use of Curcumin for the treatment of renal disorders: A systematic review of randomized controlled trials. Adv. Exp. Med. Biol. 1291, 327–343. https://doi.org/10.1007/978-3-030-56153-6_19 (2021).
Hassaniazad, M. et al. A triple-blind, placebo-controlled, randomized clinical trial to evaluate the effect of curcumin-containing nanomicelles on cellular immune responses subtypes and clinical outcome in COVID-19 patients. Phytother Res. 35 (11), 6417–6427. https://doi.org/10.1002/ptr.7294 (2021).
Ahmadi, R. et al. Oral nano-curcumin formulation efficacy in the management of mild to moderate outpatient COVID-19: A randomized triple-blind placebo-controlled clinical trial. Food Sci. Nutr. 9 (8), 4068–4075. https://doi.org/10.1002/fsn3.2226 (2021).
Honarkar Shafie, E. et al. Effect of Nanocurcumin supplementation on the severity of symptoms and length of hospital stay in patients with COVID-19: A randomized double-blind placebo-controlled trial. Phytother Res. 36 (2), 1013–1022. https://doi.org/10.1002/ptr.7374 (2022).
Mahluji, S., Ostadrahimi, A., Mobasseri, M., Ebrahimzade Attari, V. & Payahoo, L. Antiinflammatory effects of Zingiber offi Cinale in type 2 diabetic patients. Adv. Pharm. Bull. 3 (2), 273–276. https://doi.org/10.5681/apb.2013.044 (2013).
Wu, Y., Serna, R., Gan, W. & Fan, Z. Different patterns of leukocyte immune responses to infection of ancestral SARS-CoV-2 and its variants. Front. Cell. Infect. Microbiol. 15, 1508120. https://doi.org/10.3389/fcimb.2025.1508120 (2025).
Askari, G. et al. The efficacy of curcumin-piperine co-supplementation on clinical symptoms, duration, severity, and inflammatory factors in COVID-19 outpatients: a randomized double-blind, placebo-controlled trial. Trials 23 (1), 472. https://doi.org/10.1186/s13063-022-06375-w (2022).
Pázmándi, K., Szöllősi, A. G. & Fekete, T. The root causes behind the anti-inflammatory actions of ginger compounds in immune cells. Front. Immunol. 15, 1400956. https://doi.org/10.3389/fimmu.2024.1400956 (2024).
Badanta, B., García, M. A., Jiménez, Á. E., Lucchetti, G. & de Diego-Cordero, R. The use of complementary and traditional medicine for the treatment of patients with COVID-19: A systematic review. Explore 19 (5), 646–662. https://doi.org/10.1016/j.explore.2023.02.005 (2023).
Kumar, B. V., Connors, T. J. & Farber, D. L. Human T cell development, localization, and function throughout life. Immunity 48 (2), 202–213. https://doi.org/10.1016/j.immuni.2018.01.007 (2018).
Sun, L., Su, Y., Jiao, A., Wang, X. & Zhang, B. T cells in health and disease. Signal. Transduct. Target. Ther. 8 (1), 235. https://doi.org/10.1038/s41392-023-01471-y (2023).
Qin, S. et al. Efficacy and safety of turmeric and Curcumin in Lowering blood lipid levels in patients with cardiovascular risk factors: a meta-analysis of randomized controlled trials. Nutr. J. 16 (1), 68. https://doi.org/10.1186/s12937-017-0293-y (2017).
Jurenka, J. S. Anti-inflammatory properties of curcumin, a major constituent of curcuma longa: a review of preclinical and clinical research. Altern. Med. Rev. 14 (2), 141–153 (2009). PMID: 19594223.
